Jaydira Del Rivero Renee N Donahue Jennifer L Marté Ann W Gramza Marijo Bilusic Myrna Rauckhorst Lisa Cordes Maria J Merino William L Dahut Jeffrey Schlom James L Gulley Ravi A Madan
10.3389/fendo.2020.00490
Front Endocrinol (Lausanne)
2020 Aug 7;11:490.
cea pd-l1 inhibitor calcitonin immunotherapy medullary thyroid cancer
CC BY
https://pubmed.ncbi.nlm.nih.gov/32849281/
Antibodies, Monoclonal, Humanized / therapeutic use B7-H1 Antigen / antagonists & inhibitors Cancer Vaccines / administration & dosage Carcinoembryonic Antigen / administration & dosage Carcinoma, Neuroendocrine / drug therapy Saccharomyces cerevisiae / immunology Thyroid Neoplasms / drug therapy Vaccines, DNA / administration & dosage
Antibodies, Monoclonal, Humanized / therapeutic use B7-H1 Antigen / antagonists & inhibitors Cancer Vaccines / administration & dosage Carcinoembryonic Antigen / administration & dosage Carcinoma, Neuroendocrine / drug therapy Saccharomyces cerevisiae / immunology Thyroid Neoplasms / drug therapy Vaccines, DNA / administration & dosage Case Reports Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't Antineoplastic Agents, Immunological / therapeutic use Carcinoma, Neuroendocrine / immunology Carcinoma, Neuroendocrine / pathology Drug Therapy, Combination Humans Immune Checkpoint Inhibitors / therapeutic use Male Middle Aged Prognosis Thyroid Neoplasms / immunology Thyroid Neoplasms / pathology Antibodies, Monoclonal, Humanized Antineoplastic Agents, Immunological B7-H1 Antigen CD274 protein, human Cancer Vaccines Carcinoembryonic Antigen Immune Checkpoint Inhibitors Vaccines, DNA yeast-CEA vaccine avelumab Thyroid cancer, medullary
PMC7427000
32849281
A Case Report of Sequential Use of a Yeast-CEA Therapeutic Cancer Vaccine and Anti-PD-L1 Inhibitor in Metastatic Medullary Thyroid Cancer
2020